Navigation Links
A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.
Date:2/21/2013

nt that owns Genzyme, will be helping to market this product. Moreover, ISIS recently earned $7.5 million payment from GlaxoSmithKline for the initiation of the Phase2/3 clinical study of ISIS-TTR, a treatment for transthyretin (TTR) amyloidosis, a genetic disease characterized by the dysfunction of peripheral nerve or heart tissues. The Full Research Report on ISIS Pharmaceuticals, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.NationalTradersAssociation.org/r/full_research_report/555f_ISIS]

--

Amgen, Inc. Research Report

Amgen reported that its late-stage pipeline is advancing, with two pivotal phase 3 trials due this year, five in 2014, and one in 2016. Analysts have been praising Amgen for its promising pipeline and its solid long-term strategy, with researchers at the Jefferies Group reiterating their buy rating on the shares of the company. The world's largest biotechnology company notes six biosimilars as its next opportunity for growth, hoping that these products would generate a combined peak of $41 billion in global sales. It is also creating a new manufacturing process that includes launching new manufacturing technologies that aim to reduce the capital needed to produce products. It is also planning to expand globally as it launches products in Japan by 2016. The Full Research Report on Amgen, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.NationalTradersAssociation.org/r/full_research_report/7b3e_AMGN]

--

Gilead Sciences, Inc. Research Report

Gilead announced results from the Phase 3 FUSION study of its Hepatitis C drug, Sofosb
'/>"/>

SOURCE National Traders Association
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Ariosa Diagnostics Announces Publication of Study on Influential Factors Affecting Fetal DNA Concentration in Blood of Pregnant Women
2. PROLOR Biotech Announces Presentation of Data on Its Long-Acting Clotting Factors at World Federation of Hemophilia World Congress
3. Pro Bono Bio Announces the Successful Development of Subcutaneous and Long-Acting Blood Factors VIIa,VIII and IX for the Treatment of Haemophilia
4. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
5. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
6. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
7. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
8. inVentiv Health Selected to Provide Sales Operations Support for Santarus
9. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
10. Hong Kong Department of Health to Combat Sudden Cardiac Arrest With Powerheart AEDs
11. Nations Best Health Care Organizations for Patient Satisfaction, Core Measures Honored by Press Ganey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... (PRWEB) August 28, 2014 Earlier this ... University in partnership with the U.S. Air Force ... biofuel. The results indicated that this type of fuel ... feedstock and will be important to America’s Eco friendly ... now has a mandate to become independent of foreign ...
(Date:8/28/2014)... Whitehouse Laboratories is excited to announce that ... PTI Inspection Systems that will enable it to ... leak testing method development and validation programs using the ... part of this agreement, Whitehouse Labs has taken delivery ... developed and manufactured by PTI. The HVLD (high ...
(Date:8/27/2014)... Rhythm, a biopharmaceutical company developing peptide therapeutics that address ... disorders, announced today that it has filed a registration ... Exchange Commission (SEC) relating to the proposed initial public ... of shares to be offered and the price range ... Citigroup and Cowen and Company will act as ...
(Date:8/27/2014)... 27, 2014   MSC , a healthcare performance ... announced the appointment of Mary Beth Loesch ... years of experience preparing companies for rapid growth and ... Vice President of Corporate Development and Healthcare. In that ... , as well as corporate strategy and marketing. Previously, ...
Breaking Biology Technology:Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 2Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 3Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 4Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 5Whitehouse Labs Renews Partnership with PTI Inspection Systems 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 3Rhythm Files Registration Statement for Proposed Initial Public Offering 2MSC names Mary Beth Loesch President and CEO 2
... Oct. 22 Insmed Inc. (Nasdaq:,INSM), a developer of ... of the recently disclosed temporary suspension,of NASDAQ,s minimum bid ... that the Company now has until March 20, 2009 ... evidence a closing bid price of $1.00 or more ...
... Oct. 22 MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: ... and commercializing novel anti-infective products, today,announced that ... to lead its field force hiring effort ... tablets, 775mg) launch. The,launch is targeted for ...
... COX) today reported financial results for the nine,months ended September 30, ... - Positive top-line results from the 302 study for naproxcinod. ... at week-13 (p naproxcinod 750 mg bid comfortably ... naproxen 500 mg bid at week-13 and 26. Blood ...
Cached Biology Technology:NASDAQ's Temporary Suspension of Minimum Bid Closing Price Rules Extends Insmed's Compliance Date to March 20, 2009 2MiddleBrook Hires TalenTactics to Recruit National Field Force 2MiddleBrook Hires TalenTactics to Recruit National Field Force 3NicOx Reports Results for the First Three Quarters of 2008 2NicOx Reports Results for the First Three Quarters of 2008 3NicOx Reports Results for the First Three Quarters of 2008 4NicOx Reports Results for the First Three Quarters of 2008 5NicOx Reports Results for the First Three Quarters of 2008 6NicOx Reports Results for the First Three Quarters of 2008 7NicOx Reports Results for the First Three Quarters of 2008 8NicOx Reports Results for the First Three Quarters of 2008 9NicOx Reports Results for the First Three Quarters of 2008 10
(Date:8/29/2014)... news release is available in German . ... key players in the natural nitrogen cycle on Earth ... specialist bacteria were thought to depend on nitrite as ... led by Holger Daims, a microbiologist at the University ... use hydrogen as an alternative source of energy. The ...
(Date:8/29/2014)... Bend them, stretch them, twist them, fold them: modern ... extraordinary technological potential, whether as artificial skin or electronic ... use remains a challenge but a new way of ... could be a game-changer. , Previous success in ... on the use of precious gold and silver nanowires. ...
(Date:8/28/2014)... of bacterial culprits that may drive inflammatory bowel diseases ... patients, own intestinal immune responses as a guide. , ... Cell . , Trillions of bacteria exist within ... in the development and progression of IBD. Yet it,s ... affect a person,s susceptibility to IBD and its potential ...
Breaking Biology News(10 mins):Hydrogen powers important nitrogen-transforming bacteria 2Hydrogen powers important nitrogen-transforming bacteria 3Copper shines as flexible conductor 2Yale study identifies possible bacterial drivers of IBD 2
... pleased to announce the publication of an up-to-date, concise ... patients. , Small Animal Regional Anesthesia and Analgesia provides ... and is organized logically by body system. , ... into one resource, Small Animal Regional Anesthesia and Analgesia ...
... Small Animal Soft Tissue Surgery offers the state-of-the-art, ... and syndromes in small animal patients, with detailed, ... surgical techniques in a well-illustrated, easy-to-follow format, the ... diseases and syndromes, with video clips and slideshows ...
... . First detected in the United States a ... at least 39 states, is wreaking havoc in homes and gardens, ... and row crops. It,s no wonder the U.S. Department of Agriculture ... But help may be on the way: USDA scientists ...
Cached Biology News:Combating USDA's top-ranked invasive insect 2
... siTrio siRNA --- a cocktail of ... gene of interestis our most popular product. ... than 75% knockdown of your target gene ... siRNA for transfection and confirmation of optimal ...
... #27295 has improved stability and convenience from the ... only has overcome this problem but also produced ... changed the formulation of HRP conjugated antibody from ... this change, the stability of the conjugate has ...
Mouse monoclonal [1.F.1] to Yersinia pestis F1 antigen ( Abpromise for all tested applications). Antigen: Purified F1 antigen of Y. pestis vaccine strain EB....
Sheep polyclonal to Salmonella Shoreditch ( Abpromise for all tested applications). Antigen: Native Salmonella shoreditch (Group D2)....
Biology Products: